Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, December 1
November 24 2015 - 5:00PM
Business Wire
- 33rd NASDAQ OMX Investor
Program -
- Piper Jaffray 27th Annual
Healthcare Conference -
- Webcasts Available Through Gilead
Corporate Website -
Gilead Sciences, Inc. (Nasdaq: GILD) today announced webcasts
from two upcoming investor conferences: the 33rd NASDAQ OMX
Investor Program in London and the Piper Jaffray 27th Annual
Healthcare Conference in New York.
Robin L. Washington, Gilead’s Executive Vice President and Chief
Financial Officer, will participate in a fireside chat at the
NASDAQ conference on Tuesday, December 1 at 10:15 a.m. Greenwich
Mean Time (5:15 a.m. Eastern Time).
Paul R. Carter, Gilead’s Executive Vice President, Commercial
Operations, will participate in a fireside chat at the Piper
Jaffray conference on Tuesday, December 1 at 9:30 a.m. Eastern
Time.
The live webcast can be accessed at the company’s Investors page
at www.gilead.com/investors. Please connect to the company’s
website at least 15 minutes prior to the start of the presentation
to ensure adequate time for any software download that may be
required to listen to the webcast. The replay will be available for
14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151124005944/en/
Gilead Sciences, Inc.Patrick O’Brien, 650-522-1936Investor
Relations
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024